{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:20:01Z","timestamp":1789518001498,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00059-025-05345-7","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:33:35Z","timestamp":1760614415000},"page":"417-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The extravascular implantable cardioverter\u2013defibrillator: technology, evidence, and clinical perspectives","Der extravaskul\u00e4re implantierbare Kardioverter-Defibrillator: Technik, Evidenz und klinische Perspektiven"],"prefix":"10.1007","volume":"50","author":[{"given":"Eleonora","family":"Angelini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Duncker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"8","key":"5345_CR1","doi-asserted-by":"publisher","first-page":"euad203","DOI":"10.1093\/europace\/euad203","volume":"25","author":"J Tfelt-Hansen","year":"2023","unstructured":"Tfelt-Hansen\u00a0J, Garcia\u00a0R, Albert\u00a0C et\u00a0al (2023) Risk stratification of sudden cardiac death: a\u00a0review. Europace 25(8):euad203. https:\/\/doi.org\/10.1093\/europace\/euad203","journal-title":"Europace"},{"issue":"5","key":"5345_CR2","doi-asserted-by":"publisher","first-page":"euad091","DOI":"10.1093\/europace\/euad091","volume":"25","author":"H K\u00f6nemann","year":"2023","unstructured":"K\u00f6nemann\u00a0H, Dagres\u00a0N, Merino\u00a0JL et\u00a0al (2023) Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects. Europace 25(5):euad91. https:\/\/doi.org\/10.1093\/europace\/euad091","journal-title":"Europace"},{"issue":"40","key":"5345_CR3","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Tfelt-Hansen\u00a0J, de Riva\u00a0M et\u00a0al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J 43(40):3997\u20134126. https:\/\/doi.org\/10.1093\/eurheartj\/ehac262","journal-title":"Eur Heart J"},{"issue":"2","key":"5345_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00399-024-01019-9","volume":"35","author":"J W\u00f6rmann","year":"2024","unstructured":"W\u00f6rmann\u00a0J, Duncker\u00a0D, Althoff\u00a0T et\u00a0al (2024) Elektrodenplatzierung in der kardialen Devicetherapie [Lead placement in cardiac implantable electronic devices]. Herzschrittmacherther Elektrophysiol 35(2):155\u2013164. https:\/\/doi.org\/10.1007\/s00399-024-01019-9","journal-title":"Herzschrittmacherther Elektrophysiol"},{"issue":"3","key":"5345_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00399-023-00954-3","volume":"34","author":"E Martens","year":"2023","unstructured":"Martens\u00a0E, Sommer\u00a0P, Johnson\u00a0V et\u00a0al (2023) Ven\u00f6se Zugangswege in der kardialen Devicetherapie [Venous access routes for cardiac implantable electronic devices]. Herzschrittmacherther Elektrophysiol 34(3):250\u2013255. https:\/\/doi.org\/10.1007\/s00399-023-00954-3","journal-title":"Herzschrittmacherther Elektrophysiol"},{"issue":"4","key":"5345_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00399-023-00963-2","volume":"34","author":"A Reinhardt","year":"2023","unstructured":"Reinhardt\u00a0A, Jansen\u00a0H, Althoff\u00a0T et\u00a0al (2023) Sondenextraktionen bei implantierbaren kardialen Devices [Lead extraction in cardiac implantable electronic devices]. Herzschrittmacherther Elektrophysiol 34(4):339\u2013350. https:\/\/doi.org\/10.1007\/s00399-023-00963-2","journal-title":"Herzschrittmacherther Elektrophysiol"},{"issue":"7","key":"5345_CR7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/europace\/euz029","volume":"21","author":"N B\u00f6geholz","year":"2019","unstructured":"B\u00f6geholz\u00a0N, Willy\u00a0K, Niehues\u00a0P et\u00a0al (2019) Spotlight on S\u2011ICD\u2122 therapy: 10\u00a0years of clinical experience and innovation. Europace 21(7):1001\u20131012. https:\/\/doi.org\/10.1093\/europace\/euz029","journal-title":"Europace"},{"issue":"9","key":"5345_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","volume":"128","author":"R Weiss","year":"2013","unstructured":"Weiss\u00a0R, Knight\u00a0BP, Gold\u00a0MR et\u00a0al (2013) Safety and efficacy of a\u00a0totally subcutaneous implantable-cardioverter defibrillator. Circulation 128(9):944\u2013953. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003042","journal-title":"Circulation"},{"issue":"21","key":"5345_CR9","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/eurheartj\/ehab921","volume":"43","author":"PD Lambiase","year":"2022","unstructured":"Lambiase\u00a0PD, Theuns\u00a0DA, Murgatroyd\u00a0F et\u00a0al (2022) Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study. Eur Heart\u00a0J 43(21):2037\u20132050. https:\/\/doi.org\/10.1093\/eurheartj\/ehab921","journal-title":"Eur Heart J"},{"issue":"7","key":"5345_CR10","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/europace\/eut370","volume":"16","author":"DA Randles","year":"2014","unstructured":"Randles\u00a0DA, Hawkins\u00a0NM, Shaw\u00a0M, Patwala\u00a0AY, Pettit\u00a0SJ, Wright\u00a0DJ (2014) How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Europace 16(7):1015\u20131021. https:\/\/doi.org\/10.1093\/europace\/eut370","journal-title":"Europace"},{"issue":"2","key":"5345_CR11","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/ehf2.13243","volume":"8","author":"C Zormpas","year":"2021","unstructured":"Zormpas\u00a0C, Silber-Peest\u00a0AS, Eiringhaus\u00a0J et\u00a0al (2021) Eligibility for subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease. ESC Heart Fail 8(2):1502\u20131508. https:\/\/doi.org\/10.1002\/ehf2.13243","journal-title":"ESC Heart Fail"},{"issue":"2","key":"5345_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10840-020-00810-1","volume":"60","author":"C Zormpas","year":"2021","unstructured":"Zormpas\u00a0C, Eiringhaus\u00a0J, Hillmann\u00a0HAK et\u00a0al (2021) Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device. J\u00a0Interv Card Electrophysiol 60(2):303\u2013311. https:\/\/doi.org\/10.1007\/s10840-020-00810-1","journal-title":"J Interv Card Electrophysiol"},{"issue":"14","key":"5345_CR13","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","volume":"387","author":"P Friedman","year":"2022","unstructured":"Friedman\u00a0P, Murgatroyd\u00a0F, Boersma\u00a0LVA et\u00a0al (2022) Efficacy and safety of an extravascular implantable cardioverter-defibrillator. N\u00a0Engl J Med 387(14):1292\u20131302. https:\/\/doi.org\/10.1056\/NEJMoa2206485","journal-title":"N Engl J Med"},{"issue":"12","key":"5345_CR14","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jacep.2020.05.029","volume":"6","author":"I Crozier","year":"2020","unstructured":"Crozier\u00a0I, Haqqani\u00a0H, Kotschet\u00a0E, a (2020) First-in-human chronic implant experience of the substernal extravascular implantable cardioverter-defibrillator. JACC Clin Electrophysiol 6(12):1525\u20131536. https:\/\/doi.org\/10.1016\/j.jacep.2020.05.029","journal-title":"JACC Clin Electrophysiol"},{"key":"5345_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.02.012","author":"I Crozier","year":"2025","unstructured":"Crozier\u00a0I, Murgatroyd\u00a0F, Amin\u00a0A et\u00a0al (2025) Periprocedural outcomes from the postmarket study of the extravascular implantable cardioverter-defibrillator: preliminary Enlighten study results and meta-analysis. Heart Rhythm. https:\/\/doi.org\/10.1016\/j.hrthm.2025.02.012","journal-title":"Heart Rhythm"},{"issue":"11","key":"5345_CR16","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.jacep.2021.03.004","volume":"7","author":"CD Swerdlow","year":"2021","unstructured":"Swerdlow\u00a0CD, Zhang\u00a0X, Sawchuk\u00a0R et\u00a0al (2021) Design and preliminary results of sensing and detection for an extravascular implantable cardioverter-defibrillator. JACC Clin Electrophysiol 7(11):1387\u20131399. https:\/\/doi.org\/10.1016\/j.jacep.2021.03.004","journal-title":"JACC Clin Electrophysiol"},{"issue":"6","key":"5345_CR17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/jce.15511","volume":"33","author":"AE Thompson","year":"2022","unstructured":"Thompson\u00a0AE, Atwater\u00a0B, Boersma\u00a0L et\u00a0al (2022) The development of the extravascular defibrillator with substernal lead placement: a\u00a0new Frontier for device-based treatment of sudden cardiac arrest. J\u00a0Cardiovasc Electrophysiol 33(6):1085\u20131095. https:\/\/doi.org\/10.1111\/jce.15511","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"5345_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jacep.2018.11.003","volume":"5","author":"LVA Boersma","year":"2019","unstructured":"Boersma\u00a0LVA, Merkely\u00a0B, Neuzil\u00a0P et\u00a0al (2019) Therapy from a\u00a0novel Substernal lead: the ASD2 study. JACC Clin Electrophysiol 5(2):186\u2013196. https:\/\/doi.org\/10.1016\/j.jacep.2018.11.003","journal-title":"JACC Clin Electrophysiol"},{"key":"5345_CR19","unstructured":"Medtronic Aurora EV-ICD\u2122 MRI SureScand\u2122 DVEA3EA. Device Manual. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf22\/P220012C.pdf. Accessed 4 Sept 2025"},{"key":"5345_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaf331","author":"H Eaton","year":"2025","unstructured":"Eaton\u00a0H, Aggour\u00a0H, Ormerod\u00a0JOM (2025) Successful implantation of an extravascular implantable cardioverter-defibrillator in a\u00a0patient with moderate pectus excavatum: a\u00a0case report. Eur Heart J Case Rep. https:\/\/doi.org\/10.1093\/ehjcr\/ytaf331","journal-title":"Eur Heart J Case Rep"},{"issue":"5","key":"5345_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.hrcr.2025.01.020","volume":"11","author":"M Garcia-Montero","year":"2025","unstructured":"Garcia-Montero\u00a0M, Metzl\u00a0MD, Dussault\u00a0C, Raymond-Paquin\u00a0A, Mond\u00e9sert\u00a0B (2025) Implantation of an extravascular implantable cardioverter-defibrillator with an atrial leadless pacemaker: Wireless meets wireless to successfully avoid implantation of a\u00a0transvenous system. Heart Rhythm Case Rep 11(5):404\u2013408. https:\/\/doi.org\/10.1016\/j.hrcr.2025.01.020","journal-title":"Heart Rhythm Case Rep"},{"issue":"1","key":"5345_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00399-023-00989-6","volume":"35","author":"K Krieger","year":"2024","unstructured":"Krieger\u00a0K, Park\u00a0I, Althoff\u00a0T et\u00a0al (2024) Perioperatives Management bei der Versorgung mit aktiven Rhythmusimplantaten [Perioperative management for cardiovascular implantable electronic devices]. Herzschrittmacherther Elektrophysiol 35(1):83\u201390. https:\/\/doi.org\/10.1007\/s00399-023-00989-6","journal-title":"Herzschrittmacherther Elektrophysiol"},{"issue":"8","key":"5345_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacep.2016.12.026","volume":"3","author":"JYS Chan","year":"2017","unstructured":"Chan\u00a0JYS, Lelakowski\u00a0J, Murgatroyd\u00a0FD et\u00a0al (2017) Novel extravascular defibrillation configuration with a\u00a0coil in the substernal space: the ASD clinical study. JACC Clin Electrophysiol 3(8):905\u2013910. https:\/\/doi.org\/10.1016\/j.jacep.2016.12.026","journal-title":"JACC Clin Electrophysiol"},{"issue":"9","key":"5345_CR24","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1111\/jce.15190","volume":"32","author":"I Crozier","year":"2021","unstructured":"Crozier\u00a0I, O\u2019Donnell\u00a0D, Boersma\u00a0L et\u00a0al (2021) The extravascular implantable cardioverter-defibrillator: the pivotal study plan. J\u00a0Cardiovasc Electrophysiol 32(9):2371\u20132378. https:\/\/doi.org\/10.1111\/jce.15190","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"5345_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00059-021-05077-4","volume":"46","author":"VF van Dijk","year":"2021","unstructured":"van Dijk\u00a0VF, Boersma\u00a0LVA (2021) Non-transvenous ICD therapy: current status and beyond. Herz 46(6):520\u2013525. https:\/\/doi.org\/10.1007\/s00059-021-05077-4","journal-title":"Herz"},{"issue":"3","key":"5345_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00399-024-01042-w","volume":"35","author":"D Duncker","year":"2024","unstructured":"Duncker\u00a0D, Albert\u00a0K, Rillig\u00a0A et\u00a0al (2024) Praktische Anleitung zur Implantation nicht-transven\u00f6ser ICD-Systeme [Practical guidance for the implantation of non-transvenous ICD systems]. Herzschrittmacherther Elektrophysiol 35(3):226\u2013233. https:\/\/doi.org\/10.1007\/s00399-024-01042-w","journal-title":"Herzschrittmacherther Elektrophysiol"},{"issue":"19","key":"5345_CR27","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1161\/CIRCULATIONAHA.110.959676","volume":"123","author":"DE Haines","year":"2011","unstructured":"Haines\u00a0DE, Wang\u00a0Y, Curtis\u00a0J (2011) Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation. Circulation 123(19):2069\u20132076. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.959676","journal-title":"Circulation"},{"issue":"7","key":"5345_CR28","doi-asserted-by":"publisher","first-page":"ytaf322","DOI":"10.1093\/ehjcr\/ytaf322","volume":"9","author":"I Duroi","year":"2025","unstructured":"Duroi\u00a0I, Amin\u00a0R, Blankoff\u00a0N, Channan\u00a0EM, le Polain de Waroux\u00a0JB (2025) Successfully escaping the pleura with the extra-vascular implantable cardioverter defibrillator lead: a\u00a0case report. Eur Heart J Case Rep 9(7):ytaf322. https:\/\/doi.org\/10.1093\/ehjcr\/ytaf322","journal-title":"Eur Heart J Case Rep"},{"issue":"9","key":"5345_CR29","doi-asserted-by":"publisher","first-page":"euae225","DOI":"10.1093\/europace\/euae225","volume":"26","author":"V Sagi","year":"2024","unstructured":"Sagi\u00a0V, Murgatroyd\u00a0F, Boersma\u00a0LVA et\u00a0al (2024) Comprehensive analysis of substernal lead removal: experience from EV ICD Pilot, Pivotal, and Continued Access Studies. Europace 26(9):euae225. https:\/\/doi.org\/10.1093\/europace\/euae225","journal-title":"Europace"},{"issue":"20","key":"5345_CR30","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/j.jacc.2021.03.329","volume":"77","author":"MK Akta\u015f","year":"2021","unstructured":"Akta\u015f\u00a0MK, Younis\u00a0A, Zareba\u00a0W et\u00a0al (2021) Survival after implantable cardioverter-defibrillator shocks. J\u00a0Am Coll Cardiol 77(20):2453\u20132462. https:\/\/doi.org\/10.1016\/j.jacc.2021.03.329","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"5345_CR31","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.hrthm.2017.07.024","volume":"14","author":"GO Ogunbayo","year":"2017","unstructured":"Ogunbayo\u00a0GO, Charnigo\u00a0R, Darrat\u00a0Y et\u00a0al (2017) Incidence, predictors, and outcomes associated with pneumothorax during cardiac electronic device implantation: a\u00a016-year review in over 3.7\u00a0million patients. Heart Rhythm 14(12):1764\u20131770. https:\/\/doi.org\/10.1016\/j.hrthm.2017.07.024","journal-title":"Heart Rhythm"},{"issue":"25","key":"5345_CR32","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","volume":"35","author":"PD Lambiase","year":"2014","unstructured":"Lambiase\u00a0PD, Barr\u00a0C, Theuns\u00a0DA et\u00a0al (2014) Worldwide experience with a\u00a0totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S\u2011ICD Registry. Eur Heart\u00a0J 35(25):1657\u20131665. https:\/\/doi.org\/10.1093\/eurheartj\/ehu112","journal-title":"Eur Heart J"},{"issue":"5","key":"5345_CR33","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/europace\/euq519","volume":"13","author":"Y Michowitz","year":"2011","unstructured":"Michowitz\u00a0Y, Lellouche\u00a0N, Contractor\u00a0T et\u00a0al (2011) Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation. Europace 13(5):683\u2013688. https:\/\/doi.org\/10.1093\/europace\/euq519","journal-title":"Europace"},{"issue":"2","key":"5345_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1540-8167.2005.00294.x","volume":"17","author":"LA Pires","year":"2006","unstructured":"Pires\u00a0LA, Johnson\u00a0KM (2006) Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough? J\u00a0Cardiovasc Electrophysiol 17(2):140\u2013145. https:\/\/doi.org\/10.1111\/j.1540-8167.2005.00294.x","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"11","key":"5345_CR35","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/europace\/euw032","volume":"18","author":"A Arenal","year":"2016","unstructured":"Arenal\u00a0A, Proclemer\u00a0A, Kloppe\u00a0A et\u00a0al (2016) Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace 18(11):1719\u20131725. https:\/\/doi.org\/10.1093\/europace\/euw032","journal-title":"Europace"},{"issue":"6","key":"5345_CR36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJMoa1915932","volume":"383","author":"RE Knops","year":"2020","unstructured":"Knops\u00a0RE, Nordkamp\u00a0OLRA, Delnoy\u00a0PHM et\u00a0al (2020) Subcutaneous or transvenous defibrillator therapy. N\u00a0Engl J Med 383(6):526\u2013536. https:\/\/doi.org\/10.1056\/NEJMoa1915932","journal-title":"N Engl J Med"},{"issue":"12","key":"5345_CR37","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1093\/europace\/euw415","volume":"19","author":"A Auricchio","year":"2017","unstructured":"Auricchio\u00a0A, Hudnall\u00a0JH, Schloss\u00a0EJ et\u00a0al (2017) Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a\u00a0systematic review and meta-analysis. Europace 19(12):1973\u20131980. https:\/\/doi.org\/10.1093\/europace\/euw415","journal-title":"Europace"},{"issue":"2","key":"5345_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/jce.16151","volume":"35","author":"SF Sears","year":"2024","unstructured":"Sears\u00a0SF, Harrell\u00a0R, Crozier\u00a0I et\u00a0al (2024) Patient-reported quality of life and acceptance of the extravascular implantable cardioverter-defibrillator: results from pivotal study. J\u00a0Cardiovasc Electrophysiol 35(2):240\u2013246. https:\/\/doi.org\/10.1111\/jce.16151","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"5345_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.124.071795","volume":"151","author":"P Friedman","year":"2025","unstructured":"Friedman\u00a0P, Murgatroyd\u00a0F, Boersma\u00a0LVA et\u00a0al (2025) Performance and safety of the extravascular Implantable cardioverter defibrillator through long-term follow-up: final results from the pivotal study. Circulation 151(4):322\u2013332. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.071795","journal-title":"Circulation"},{"issue":"8","key":"5345_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1161\/CIRCEP.123.011922","volume":"16","author":"MC Burke","year":"2023","unstructured":"Burke\u00a0MC, Knops\u00a0RE, Reddy\u00a0V et\u00a0al (2023) Initial experience with intercostal insertion of an extravascular ICD lead compatible with existing pulse generators. Circ Arrhythm Electrophysiol 16(8):421\u2013432. https:\/\/doi.org\/10.1161\/CIRCEP.123.011922","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"5345_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae666.715","author":"MC Burke","year":"2024","unstructured":"Burke\u00a0MC, Doshi\u00a0S, Ebner\u00a0A et\u00a0al (2024) Pacing sensation with a\u00a0second generation intercostal extravascular ICD lead. Eur Heart\u00a0J. https:\/\/doi.org\/10.1093\/eurheartj\/ehae666.715","journal-title":"Eur Heart J"},{"issue":"3","key":"5345_CR42","doi-asserted-by":"publisher","first-page":"euaf044","DOI":"10.1093\/europace\/euaf044","volume":"27","author":"SK Doshi","year":"2025","unstructured":"Doshi\u00a0SK, Knops\u00a0RE, Ebner\u00a0A et\u00a0al (2025) Evaluation of a\u00a0second-generation intercostal extravascular implantable cardioverter defibrillator lead with a\u00a0pectoral pulse generator for sensing, defibrillation, and anti-tachycardia pacing. Europace 27(3):euaf44. https:\/\/doi.org\/10.1093\/europace\/euaf044","journal-title":"Europace"},{"issue":"7","key":"5345_CR43","doi-asserted-by":"publisher","first-page":"euaf128","DOI":"10.1093\/europace\/euaf128","volume":"27","author":"M Biffi","year":"2025","unstructured":"Biffi\u00a0M, Quaranta\u00a0A, Carecci\u00a0A et\u00a0al (2025) The extravascular implantable defibrillator: a\u00a0novel opportunity for the paediatric population. Europace 27(7):euaf128. https:\/\/doi.org\/10.1093\/europace\/euaf128","journal-title":"Europace"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05345-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-025-05345-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05345-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:19:16Z","timestamp":1764249556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-025-05345-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5345"],"URL":"https:\/\/doi.org\/10.1007\/s00059-025-05345-7","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"22 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.\u00a0Duncker received moderate speaker fees, travel grants, and\/or a fellowship grant from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, and ZOLL. E.\u00a0Angelini and K.\u00a0Albert declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}